The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy

Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy

(2014) Olga Moshkin et al.   Hormones-International Journal of Endocrinology and Metabolism

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

(2013) Antonio Bianchi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma

(2012) Jonathan E. Dowell et al.   LUNG CANCER

Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

(2012) Teresa Gagliano et al.   Pituitary

O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas

(2011) Fateme Salehi et al.   NEUROSURGERY

Anti-VEGF therapy in pituitary carcinoma

(2011) Leon D. Ortiz et al.   Pituitary

Treatment of pituitary neoplasms with temozolomide

(2010) Luis V. Syro et al.   CANCER

Low Immunohistochemical Expression of MGMT in ACTH Secreting Pituitary Tumors of Patients with Nelson Syndrome

(2010) Fateme Salehi et al.   ENDOCRINE PATHOLOGY

Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression

(2010) Zachary M. Bush et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease

(2009) Akira Takeshita et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues

(2009) M. Sherlock et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas

(2009) Christiaan de Bruin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MASEP gamma knife radiosurgery for secretory pituitary adenomas: experience in 347 consecutive cases

(2009) Heng Wan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

(2008) Ann I. McCormack et al.   CLINICAL ENDOCRINOLOGY

Medical therapy for clinically non-functioning pituitary adenomas

(2008) A. Colao et al.   ENDOCRINE-RELATED CANCER

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro

(2008) C de Bruin et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment

(2008) Masamichi Kurosaki et al.   NEUROLOGICAL RESEARCH

Medical therapy of pituitary adenomas: Effects on tumor shrinkage

(2008) Annamaria Colao et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS